1.

[Article] Rock, Kirsten L and Frinculescu, Anca and Shine, Trevor and Kalk, Nicola J and Copeland, Caroline S (2025) Impact of 'street' benzodiazepines on drug-related deaths in England, Wales and Northern Ireland. Drug and Alcohol Review, 41, (1), pp. 355-365. https://doi.org/10.1111/dar.13979

2.

[Article] Spinazzola, Edoardo and Degen, Hannah and Austin-Zimmerman, Isabelle and Trotta, Giulia and Chesney, Edward and Li, Zhikun and Alameda, Luis and Leung, Bok Man and Lang, Yifei and Quattrone, Andrea and Quattrone, Diego and Castrignanò, Erika and Wolff, Kim and Murray, Robin and Freeman, Tom P and Di Forti, Marta (2025) Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology? BMJ Mental Health, 28. https://doi.org/10.1136/bmjment-2025-301810

3.

[Article] Hessler, Meaghan R and Kacinko, Sherri L and Logan, Barry K (2025) Drug-facilitated crime: a review of findings between 2019 and 2023. Journal of Forensic Sciences, Early online. https://doi.org/10.1111/1556-4029.70151

4.

[Article] Li, Sophie and Solmi, Marco and Myran, Daniel T and Fabiano, Nicholas (2025) Cannabis and psychosis. Canadian Medical Association Journal, 197, (27). DOI: https://doi.org/10.1503/cmaj.250659

5.

[Article] Marland, Victoria and Nisbet, Lorna and Nic Daéid, Niamh (2025) Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. Harm Reduction Journal, 22. https://doi.org/10.1186/s12954-025-01287-9

6.

[Video] Darke, Shane (2025) NDARC webinar series presentation. Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000-2025. National Drug and Alcohol Research Centre, UNSW Sydney.

7.

[Article] Piatkowski, Timothy and Kill, Emma and Reeve, Steph (2025) ‘The gear could be cut with fentanyl which is starting to happen more in Australia’: exploring overdose survivors’ perspectives on toxic supply and safe consumption. Drugs: Education Prevention and Policy, 32, (1), pp. 42-50. https://doi.org/10.1080/09687637.2024.2392520

8.

[Webpage] Center for Forensic Science Research and Education. (2025) CSFRE new psychoactive substances (NPS). Scope recommendations. URL: https://www.cfsre.org/nps-discovery/scope-recommen...

9.

[Report] Public Health Scotland. (2025) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2025. Edinburgh: Public Health Scotland.

10.

[Report] United Nations Office on Drugs and Crime, World Health Organization. (2025) Contaminated medicines and integrity of the pharmaceutical excipients supply chain. Vienna: UNODC and WHO.

11.

[Article] Sarıbaş, Kürşat and Akpınar, Ayça Açıkalın and Özşeker, Pınar Efeoğlu and Taşkın, Ömer and Dişel, Nezihat Rana and Devecioğlu, Gül Filiz (2025) Methanol poisoning in the emergency department: methanol blood levels, prognosis, and sequelae outcomes. Irish Journal of Medical Science, Early online. https://doi.org/10.1007/s11845-025-03982-9

12.

[Report] European Union Drugs Agency. (2025) Drug supply, production and precursors – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

13.

[Report] European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance 2-methylmethcathinone (2-MMC). Lisbon: EUDA.

14.

[Report] European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance 4-bromomethcathinone (4-BMC). Lisbon: EUDA.

15.

[Report] European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance N-ethylnorpentedrone (NEP). Lisbon: EUDA.

16.

[Dataset] European Union Drugs Agency. (2025) EUDA statistical bulletin - data and statistics on the drug situation in Europe.

17.

[Report] European Union Drugs Agency. (2025) MDMA – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

18.

[Report] European Union Drugs Agency. (2025) Understanding Europe’s drug situation in 2024 – key developments (European Drug Report 2025). Lisbon: EUDA.

19.

[Article] Stangeland, Marcus and Dale, Ola and Skulberg, Arne Kristian (2025) Nitazenes: review of comparative pharmacology and antagonist action. Clinical Toxicology, 63, (6), pp. 393-406. https://doi.org/10.1080/15563650.2025.2504133

20.

[Article] HSE drugs.ie. (2025) HSE Ketamine update 2025. drugs.ie,

21.

[Article] HSE drugs.ie. (2025) HSE MDMA update May 2025. drugs.ie,

22.

[Article] Nham, Amy and Le, John N and Thomas, Shawn A and Gressick, Kimberly and Ussery, Emily N and Ko, Jean Y and Gladden, R Matt and Mikosz, Christina A and Schier, Joshua G and Vivolo-Kantor, Alana and Fiorillo, Maria and McMaster, McKenna and Magana, Darlene Nolasco and Verklan-McInnes, Livia and Wahl, Michael and Wood, Taylor and Adams, Axel and Krotulski, Alex and Trecki, Jordan and Ellison, Ross and Gerona, Roy and Arunkumar, Ponni and Mir, Mojde and Wise, Leslie M and Betancourt, Emma and Monty, Kathleen and Gulmatico, Jhoanna and Pojas, Angie and Fitzgerald, Ruchi and Hua, Miao (2025) Overdoses involving medetomidine mixed with opioids - Chicago, Illinois, May 2024. MMWR. Morbidity and mortality weekly report, 74, (15), pp. 258-265. /10.15585/mmwr.mm7415a1

23.

[Report] Advisory Council on the Misuse of Drugs. (2025) ‘Semi-synthetic’ cannabinoids: cannabinoids related to tetrahydro- cannabinol and cannabidiol. London: Advisory Council on the Misuse of Drugs.

24.

[Report] Center for Forensic Science Research and Education. (2025) An update on the presence of BTMPS in the drug supply and the discovery of tetramethylfentanyl-related substances. United States: Center for Forensic Science Research and Education.

25.

[Webpage] HSE drugs.ie. (2025) Drug trend updates and warnings. URL: https://www.drugs.ie/drugs_info/drug_trend_updates...

26.

[Webpage] Center for Forensic Science Research and Education. (2025) Novel psychoactive substances (NPS) trend reports. URL: https://www.cfsre.org/nps-discovery/trend-reports

27.

[Article] Gonzalez-Nieto, Pablo and Wallace, Bruce and Kielty, Collin and Gruntman, Kayla and Robinson, Derek and Gill, Chris and Arredondo Sanchez Lira, Jaime and Hore, Dennis (2025) Not just fentanyl: understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada. International Journal of Drug Policy, 138. https://doi.org/10.1016/j.drugpo.2025.104751

28.

[Video] Royal College of Surgeons in Ireland. (2025) RCSI MyHealth Series 2024/25. Cannabis and young minds: what parents and families should know. RCSI.

29.

[Article] Meshkat, Shakila and Al-Shamali, Huda and Perivolaris, Argyrios and Tullu, Trusha and Zeifman, Richard J and Zhang, Yanbo and Burback, Lisa and Winkler, Olga and Greenshaw, Andrew and Husain, Muhammad Ishrat and C Reichelt, Amy and Vermetten, Eric and Jha, Manish K and Jetly, Rakesh and Loebenberg, Raimar and Bhat, Venkat (2025) Pharmacokinetics of psilocybin: a systematic review. Pharmaceutics, 17, (4). https://doi.org/10.3390/pharmaceutics17040411

30.

[Report] European Drugs Agency. (2025) Wastewater analysis and drugs — a European multi-city study. Lisbon: European Drugs Agency.

31.

[Report] United Kingdom. Home Office. (2025) Wastewater analysis: measuring illicit drug consumption in 2023 and 2024. London: Home Office.

32.

[Article] Pourebrahim, Sepehr and Ahmad, Tooba and Rottmann, Elisabeth and Schulze, Johannes and Scheller, Bertram (2025) Does cannabis use contribute to schizophrenia? A causation analysis based on epidemiological evidence. Biomolecules, 15, (3). https://doi.org/10.3390/biom15030368

33.

[Article] Albrecht, Matthew A and Hasan, Razi and Kekez, Damir and Zhou, Huaqiong (2025) Dose-response relationship between blood concentrations of THC and crash culpability risk: an updated meta-regression of culpability studies. Drug Science, Policy and Law, Early online. https://doi.org/10.1177/20503245251323344

34.

[Article] Gardner, Matthew and Bowden, Celeste and Manzoor, Shoaib and Cozier, Gyles E and Andrews, Rachael C and Craft, Sam and Skumlien, Martine and Sunderland, Peter and Tooth, Tom and Collins, Peter and Power, Alexander and Haines, Tom SF and Freeman, Tom P and Scott, Jennifer and Sutcliffe, Oliver B and Bowman, Richard W and Husbands, Stephen M and Pudney, Christopher R (2025) Field-portable device for detection of controlled and psychoactive substances from e-cigarettes. ACS Omega, 10, (8), pp. 7839-7847. https://doi.org/10.1021/acsomega.4c08614

35.

[Report] TEDI members. Jones, G and Ventura, Mireia and Rigoni, Rafaela and Schiffer, Katrin (2025) European drug checking trends 2018 - 2024. Amsterdam: Correlation – European Harm Reduction Network.

36.

[Article] Killoran, Sarah and McNamara, Sinéad and Kavanagh, Pierce and O'Brien, John and Lakes, Rodney (2025) Identification of N-pyrrolidino protonitazene in powders sold as heroin and associated with overdose clusters in Dublin and Cork, Ireland. Drug Testing and Analysis, 17, (3), pp. 350-357. https://doi.org/10.1002/dta.3707

37.

[Report] MEDICRIME Unit, Directorate General: Human Rights and Rule of Law. (2025) An assessment of publicly reported incidents of illicit diversion and falsification of medicines. Strasbourg: European Commission.

38.

[Article] van Amsterdam, Jan and van den Brink, Wim (2025) Explaining the high mortality among opioid-cocaine co-users compared to opioid-only users. a systematic review. Journal of Addictive Diseases, 43, (2), pp. 121-131. https://doi.org/10.1080/10550887.2024.2331522

39.

[Article] Cairns, Rose and Allaf, Sara and Buckley, Nicholas A (2025) Cannabis poisonings in Australia following the legalisation of medicinal cannabis, 2014-24: analysis of NSW Poisons Information Centre data. The Medical Journal of Australia, 222, (3), pp. 155-157. https://doi.org/10.5694/mja2.52586

40.

[Report] Advisory Council on the Misuse of Drugs. (2025) Synthetic cathinones: an updated harms assessment. London: Advisory Council on the Misuse of Drugs.